Cerity Partners’s Ardelyx ARDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$364K Buy
71,436
+2,671
+4% +$16.3K ﹤0.01% 2652
2026
Q1
$412K Buy
68,765
+9,406
+16% +$62.2K ﹤0.01% 2403
2025
Q4
$346K Buy
59,359
+2,972
+5% +$16.6K ﹤0.01% 2318
2025
Q3
$311K Sell
56,387
-49,139
-47% -$267K ﹤0.01% 2259
2025
Q2
$414K Buy
105,526
+31,757
+43% +$131K ﹤0.01% 1973
2025
Q1
$362K Buy
73,769
+55,569
+305% +$298K ﹤0.01% 1927
2024
Q4
$96K Sell
18,200
-8,531
-32% -$47.1K ﹤0.01% 2334
2024
Q3
$184K Buy
+26,731
New +$158K ﹤0.01% 2338

Other funds holding ARDX

Cerity Partners's ARDX Position: Q2 2026 in Review

Cerity Partners increased its Ardelyx (ARDX) stake by 3.9% in Q2 2026, buying an estimated $16.3K and bringing the position to 71,436 shares worth $364K. The position accounts for ﹤0.01% of the portfolio, ranked #2652.

Cerity Partners first reported a position in ARDX in Q3 2024 and has held it in 8 quarters since. The position peaked at $414K in Q2 2025. 250 funds tracked by Wall St. Rank hold ARDX as of Q2 2026.

  • Cerity Partners held 71,436 shares of Ardelyx worth $364K as of Q2 2026.
  • Cerity Partners bought 2,671 Ardelyx shares in Q2 2026, an estimated $16.3K.
  • Ardelyx made up ﹤0.01% of Cerity Partners's portfolio in Q2 2026, its #2652 holding.
  • Cerity Partners first reported a position in Ardelyx in Q3 2024 and has held it in 8 quarters since.
  • Cerity Partners's Ardelyx position peaked at $414K in Q2 2025.
  • 250 funds tracked by Wall St. Rank held Ardelyx as of Q2 2026.

Based on Cerity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.